![Scientific Studies | TED Symptoms | TED Clinical Trials Enrollment](https://thyroideyestreatment.com/wp-content/uploads/2024/04/pubmed.png)
Teprotumumab for the treatment of Thyroid eye disease – PubMed
![Scientific Studies | ASOPRS | TED Clinical Trials](https://thyroideyestreatment.com/wp-content/uploads/2024/05/asoprs_2022_logo.png)
Acquired Epiblepharon Alleviated With Teprotumumab Treatment in Active Thyroid Eye Disease Patient
![Springer-Link | Bulging Eyes Thyroid Disease | Clinical Trials for Thyroid Eye Disease](https://thyroideyestreatment.com/wp-content/uploads/2024/04/Springer-Link-new-logo.png)
Teprotumumab improves light sensitivity in patients with thyroid eye disease
![Scientific Studies | American Academy-of Ophthalmology | TED Clinical Trials](https://thyroideyestreatment.com/wp-content/uploads/2024/04/american-academy-of-ophtalmology-new.png)
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment
![Scientific Studies | PRS Global Open | Thyroid Eye Disease Trials](https://thyroideyestreatment.com/wp-content/uploads/2024/04/prs-global-open-new.png)
Facial and Eyelid Changes in Thyroid Eye Diseases Are Reversed by Teprotumumab
![Scientific Studies | JCEM | Thyroid Eye Disease Clinical Trials](https://thyroideyestreatment.com/wp-content/uploads/2024/04/jcem.png)
Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity
![Scientific Studies | TED Symptoms | TED Clinical Trials Enrollment](https://thyroideyestreatment.com/wp-content/uploads/2024/04/pubmed.png)